Skip to main content
Joseph Stevenson, DO, Cardiology, Reno, NV, Northern Nevada Medical Center

JosephPStevensonDOFACC

Cardiology Reno, NV

Pulmonary Arterial Hypertension; Congestive Heart Failure

Dr. Stevenson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stevenson's full profile

Already have an account?

Summary

  • Associate Clinical Professor of Medicine
    University School of Medicine Reno Nevada

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterFellowship, Cardiovascular Disease, 1997 - 2000
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1994 - 1997
  • Chicago Osteopathic Medical Center
    Chicago Osteopathic Medical CenterInternship, Transitional Year, 1993 - 1994
  • Chicago College of Osteopathic Medicine at Midwestern University
    Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1993
  • Southern Illinois University
    Southern Illinois UniversityBA, Physiology , 1985 - 1988
  • Triton Community College
    Triton Community CollegeAAS, Respiratory Therapy , Honors, 1982 - 1984

Certifications & Licensure

  • NV State Medical License
    NV State License 2000 - 2024
  • CA State Medical License
    CA State License 2000 - 2021
  • IL State Medical License
    IL State License 1993 - 2002
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Fellow (FACC) American College of Cardiology

Committees

  • Chief of Staff, Medical executive committee 2020 - 2022
  • Vice Chief of Staff, Medical Executive Committee 2018 - 2020
  • Secretary, Medical Executive Committee 2016 - 2018

Research History

  • Primary investigator UNISUS TrialEvaluating Opsumet in WHO Group 1 PAH with dosing of 75mg vs 10mg.2019 - 2025
  • Primary InvestigatorThe Increase Trial Tyvaso in the treatment patients with WHO Group 3 pulmonary arterial hypertension and interstitial lung disease.2017 - 2020
  • Primary InvestigatorOpus Trial Macitentan in the treatment of WHO Group 1 pulmonary arterial hypertension.2016 - 2020

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Consultant, United Therapeutics2014 - 2023
  • Consultant, Actelion2006 - 2023